The Interplay Between Coagulation and Inflammation Pathways in COVID-19-Associated Respiratory Failure: A Narrative Review
Abstract The novel coronavirus disease (COVID-19) pandemic has caused an unprecedented worldwide socio-economic and health impact. There is increasing evidence that a combination of inflammation and hypercoagulable state are the main mechanisms of respiratory failure in these patients. This narrativ...
Main Authors: | Rajat Bhattacharyya, Prasad Iyer, Ghee Chee Phua, Jan Hau Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-08-01
|
Series: | Pulmonary Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s41030-020-00126-5 |
Similar Items
-
COVID-19 complicated by acute arterial thrombosis: Therapeutic challenges
by: Hammam Shereef, et al.
Published: (2020-12-01) -
Disseminated intravascular coagulation
by: A Venugopal
Published: (2014-01-01) -
Myricetin protects against lipopolysaccharide-induced disseminated intravascular coagulation by anti-inflammatory and anticoagulation effect
by: Jing-Yi Tan, et al.
Published: (2018-01-01) -
Comparison of aPTT and CT Parameter of the ROTEM Test to Monitor Heparin Anti-Coagulation Effect in ICU Patients: an Observational Study
by: Atabak Najafi, et al.
Published: (2015-10-01) -
Impact of anti-aggregant, anti-coagulant and non-steroidal anti-inflammatory drugs on hospital outcomes in patients with peptic ulcer bleeding
by: Tevfik Solakoglu, et al.
Published: (2014-01-01)